8409.TWO · EBM
Taiwan · RS rating 20 · As of 2026-10-08
| Price | 17.90 TWD |
|---|---|
| 1-day change | -0.6% |
| RS rating (overall / 1M / 3M / 12M) | 20 / 37 / 39 / 23 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 13 / 26 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -30.8% |
| Distance from 52-week high | +29.4% |
| Market cap (USD) | $18.1M |